Research in Stevens-Johnson syndrome/toxic epidermal necrolysis (TEN): a network of specialist TEN centres is needed to undertake effective clinical studies and therapeutic trials

Br J Dermatol. 2013 Dec;169(6):1177. doi: 10.1111/bjd.12710.
No abstract available

Publication types

  • Comment

MeSH terms

  • Female
  • Humans
  • Immunoglobulins, Intravenous / therapeutic use*
  • Immunologic Factors / therapeutic use*
  • Male
  • Stevens-Johnson Syndrome / drug therapy*

Substances

  • Immunoglobulins, Intravenous
  • Immunologic Factors